GeneDx Holdings Corp. (WGSWW NASDAQ) stock market data APIs
$0.0638
0.02(31.3%)
as of May 8, 2025
GeneDx Holdings Corp. Financial Data Overview
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company is headquartered in Stamford, Connecticut.
Prev. Close
0.0638
Open
0.0803
High
0.0793
Low
0.0629
52 wk Range
0.0184-0.341
Market Cap
0
Revenue
330 M
Beta
2.004
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GeneDx Holdings Corp. data using free add-ons & libraries
Get GeneDx Holdings Corp. Fundamental Data
GeneDx Holdings Corp. Fundamental data includes:
- Net Revenue: 330 M
- EBITDA: 8 846 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GeneDx Holdings Corp. News
New
GeneDx Announces Completion of Fabric Genomics Acquisition
Closing unlocks the next phase of genomic medicine, enabling an end-to-end centralized and decentralized model for offering clinically-actionable genomic insights at a global scale GAITHERSBURG, Md. ...
Best Momentum Stocks to Buy for May 5th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 5th: GeneDx Holdings Corp. WGS: This genomics-related diagnostic and information services ...
New Strong Buy Stocks for May 5th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: GeneDx Holdings Corp. WGS: This genomics-related diagnostic and information services company has seen the Zacks Consensus Esti...
Why Investors Were Avoiding GeneDx Holdings Stock This Week
Key Points The company crushed analyst estimates in its first quarter, but for many investors it didn't crush them enough. Regardless, several analysts cut their price targets just after the earnings...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
